Skip to main content
. 2018 Jan 19;110(7):726–733. doi: 10.1093/jnci/djx270

Figure 2.

Figure 2.

Kaplan-Meier analyses by intratumor heterogeneity of estrogen receptor (ER) and trial arm (four groups: low intratumor heterogeneity of ER/treated arm, low heterogeneity/untreated arm, high heterogeneity/treated arm, high heterogeneity/untreated arm). The P value is based on a two-sided log-rank test; numbers at risk are shown underneath each graph.